What We're Reading: Page 126
Industry reads hand-picked by our editors
May 27, 2022
May 26, 2022
-
Associated Press
FDA chief struggles to explain slow response on baby formula
-
Boston Business Journal
Mass. life sciences leaders urge action on 'epidemic' of gun violence
-
Bloomberg
Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit
-
The Wall Street Journal
Biotech Founder Arrested in Murder-for-Hire Scheme
May 25, 2022
-
Stat
Viruses on hiatus during Covid are back — and behaving in unusual ways
-
Axios
Washington once again targets prescription drug middlemen
-
Endpoints News
Moderna seeks to dismiss Alnylam suit over Covid-19 vaccine component, claiming wrong venue
-
PharmaVoice
First 90 Days: Syneos Health's Michelle Keefe
May 24, 2022
-
The Wall Street Journal
Covid-19 Vaccine and Drug Sales, Once Booming, Plateau
-
Reuters
China Junshi's potential COVID drug shows promise in small trial
-
FierceBiotech
Genocea closes up shop after cash reserves dry up
May 23, 2022
May 20, 2022
-
STAT
CDC advisory committee recommends Covid boosters for kids ages 5 to 11
-
The Boston Globe
This startup aims to make contraceptives that prolong fertility, delay menopause, and improve women’s health
-
Endpoints News
Flagship’s Foghorn, partnered with Merck and Eli Lilly, gets a partial FDA hold after patient death
May 19, 2022
-
Evaluate Vantage
Investors bite the big pharma hands that feed them
-
Bloomberg
Insiders Bemoan Culture, Data Gaps That Limit CDC in Crises
-
The Wall Street Journal
Drugmaker Endo Begins Debt-Restructuring Talks With Creditors Amid Opioid Litigation
-
Stat
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak
Previous
